[Pulsatile fluctuation of human luteinizing hormone (hLH) in normal menstrual cycle, as assessed by the in vitro bioassay and improved radioimmunoassay]. 1982

Y Koizumi

Plasma samples obtained by continuous withdrawal for a 10-hour period in normal menstrual cycle were assayed for human luteinizing hormone (hLH) by both the in vitro bioassay and improved radioimmunoassay (RIA). The pulsatile patterns of both biological and immunological hLH levels were demonstrated with high frequency and low amplitude in the follicular phase and with low frequency and high amplitude in the luteal phase in the present study, as seen in the literature, although the assay procedures were different. The basal levels of immunoreactive hLH were 17.99mIU/ml with 95% confidence limits at 14.49 and 22.34mIU/ ml in the follicular phase and 10.79 (6.62 : 17.58) mIU/ml in the luteal phase. These two values were comparable to those in the literature. On the other hand, those of bioreactive hLH in the corresponding phases were 21.68 (15.21 : 30.90) mIU/ml and 6.22 (4.94 : 7.83) mIU/ml, respectively. The differences of the basal levels in these two phases were more pronouncedly assessed by the bioassay than by the RIA. The ratios of biological to immunological hLH activities (B/I ratios) at the trough (base) were over the unity (1.21 (1.03 : 1.41) ) in the follicular phase, whereas those in the luteal phase were decreased down to 0.58 (0.44 : 0.76). This depression is likely due to the poor specificity of the antiserum employed in the RIA. The half disappearance times (t1/2's) of the immunoreactive hLH were shortened significantly in the preovulatory phase(83.7(64.3 : 103.1)min)in comparison with those of the bioreactive hLH(122.9(98.2 : 147.6) min). The B/I ratios at the peaks of the pulses were depressed down in the preovulatory phase. The possible existence of hLH with immunoactivity and no, or little, bioactivity was suggested from these two evidences in this stage of menstrual cycle. The difference in the t1/2's of bioreactive hLH in the follicular and luteal phase (103.6 (94.7 : 112.5) min and 87.2 (72.5 : 101.9) min, respectively) indicated proportional differences of hLH subpopulations with various clearance rates in these two phases.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D008183 Luteal Phase The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. Menstrual Cycle, Luteal Phase,Menstrual Cycle, Secretory Phase,Menstrual Secretory Phase,Postovulatory Phase,Phase, Luteal,Phase, Postovulatory,Secretory Phase, Menstrual
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D005498 Follicular Phase The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION. Menstrual Cycle, Follicular Phase,Menstrual Cycle, Proliferative Phase,Menstrual Proliferative Phase,Preovulatory Phase,Phase, Follicular,Phase, Menstrual Proliferative,Phase, Preovulatory,Proliferative Phase, Menstrual
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001681 Biological Assay A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. Bioassay,Assay, Biological,Assays, Biological,Biologic Assay,Biologic Assays,Assay, Biologic,Assays, Biologic,Bioassays,Biological Assays

Related Publications

Y Koizumi
December 1966, The Journal of clinical endocrinology and metabolism,
Y Koizumi
September 1979, American journal of obstetrics and gynecology,
Y Koizumi
December 1988, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
Y Koizumi
March 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y Koizumi
August 1969, Horumon to rinsho. Clinical endocrinology,
Copied contents to your clipboard!